Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2025-09-26 00:00:00 ET · period of report 2025-09-23 · accession 0001193125-25-221028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-09-26 | 2025-09-23 | FDMT | Bizily Scott | CLO | S - Sale | $8.00 | -2,407 | 7,596 | -24% | -$19.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-23 | S | D | 2,407 | $8.00 | 7,596 | D | — | — | (F2) Reflects 3,222 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |